Abstract
An estimated 130–170 million people worldwide are chronically infected with HCV.1 In Europe the highest prevalence of HCV infections is in the IDU population.2 As traditional HCV screening relies on the detection of HCV antibody or HCV RNA in blood, screening in high-risk groups such as IDU is difficult due to poor venous access caused by damaged veins.
Original language | English |
---|---|
Pages (from-to) | 106-109 |
Number of pages | 4 |
Journal | Journal of Clinical Virology |
Volume | 54 |
Issue number | 2 |
DOIs | |
Publication status | Published - 2012 |
Keywords
- HCV
- RNA
- blood
- hepatitis C
- virology